Our Services
Medical Information
Helpful Resources
Published on: 2/7/2026
For adults over 65, Vraylar may help with schizophrenia, bipolar I episodes, and as an add-on for major depression, but it requires careful use. There are several factors to consider, including the boxed warning in dementia-related psychosis, higher risks of movement symptoms, dizziness and falls, and metabolic changes; see details below. Doctors often start low and go slow, monitor weight, glucose, cholesterol, blood pressure, review other medications, and watch for delayed side effects since it stays in the body a long time; never stop it on your own and seek urgent care for severe confusion, fever with stiffness, fainting, or suicidal thoughts. Important nuances, alternatives, and what to discuss with your clinician are explained below to guide your next steps.
Mental health conditions such as depression, bipolar disorder, and schizophrenia do not disappear with age. In fact, they can become more complex in later life due to physical health changes, medications, and life transitions. One medication that may be discussed in this context is Vraylar (cariprazine). If you or a loved one is over 65 and considering or already taking Vraylar, understanding how it works and what to watch for is essential.
This article explains Vraylar in clear, everyday language, with a focus on safety, effectiveness, and special considerations for older adults. The goal is to inform without causing unnecessary worry—while still being honest about important risks.
Vraylar is a prescription antipsychotic medication. It is approved to treat:
Vraylar works by affecting certain brain chemicals, mainly dopamine and serotonin, which play key roles in mood, thinking, and behavior.
Yes, Vraylar may be prescribed to adults over 65, but it requires careful consideration. Older adults often respond differently to medications than younger people due to:
Clinical studies of Vraylar included adults, but like many psychiatric medications, there is less data specifically focused on seniors. This does not mean it cannot be used—it means doctors must individualize treatment and monitor closely.
A healthcare provider may consider Vraylar for an older adult if:
Mental health conditions can be serious at any age. Untreated or poorly treated illness can increase the risk of hospitalization, functional decline, and reduced quality of life.
Like all antipsychotic medications, Vraylar carries a boxed warning for older adults with dementia-related psychosis. Studies have shown an increased risk of death in this group, mostly due to heart-related events or infections.
Older adults may be more sensitive to movement symptoms, including:
These effects can increase the risk of falls, which is a major concern in seniors.
Vraylar may affect:
While Vraylar tends to cause less weight gain than some other antipsychotics, regular monitoring is still important, especially in seniors with diabetes or heart disease.
Not everyone experiences side effects, but those reported more often include:
In adults over 65, dizziness and blood pressure changes can be more significant and may contribute to falls. Any new or worsening symptoms should be reported promptly.
Doctors usually follow a "start low and go slow" approach with seniors:
Monitoring may include:
Because Vraylar stays in the body for a long time, side effects may appear days or even weeks after a dose change.
Depression, mood changes, and unusual behavior are sometimes mistaken as "just part of aging." They are not. If you or a loved one is experiencing:
It's important to take action. You can start by using a free, AI-powered tool to check your Depression symptoms and better understand what you may be experiencing—this can help you have a more informed conversation with your healthcare provider about next steps.
For some seniors, Vraylar can improve mood stability, reduce severe symptoms, and support better daily functioning. For others, the risks may outweigh the benefits. There is no one-size-fits-all answer.
Key questions to discuss with a doctor include:
While most side effects are manageable, seek medical care right away if any of the following occur:
These can be serious or life-threatening and should not wait.
If you are over 65 and considering Vraylar—or already taking it—speak to a doctor about any concerns, especially if symptoms feel severe, sudden, or frightening. Never stop or change the dose of Vraylar on your own, as this can cause symptoms to worsen.
A healthcare provider can help weigh the risks and benefits, adjust treatment if needed, and ensure that mental health care supports both safety and quality of life.
Aging brings changes, but mental health treatment remains important and effective when handled carefully. Vraylar may be a helpful option for some seniors, particularly when symptoms are significant and other treatments have not worked. With thoughtful dosing, close monitoring, and open communication with a doctor, many older adults can use Vraylar safely.
The most important step is staying informed, paying attention to changes, and involving a trusted healthcare professional in every decision—especially when life-threatening or serious symptoms are possible.
(References)
* D'Souza, L., Alphs, L., Németh, G., Szatmári, L., & Pikalov, A. A. (2019). Safety and Tolerability of Cariprazine in Elderly Patients with Schizophrenia: A Post Hoc Analysis of Pooled Data. *CNS drugs*, *33*(9), 899-911.
* D'Souza, L., Pikalov, A. A., Lu, K., Szatmári, L., Németh, G., & Alphs, L. (2021). Efficacy and Safety of Cariprazine in Elderly Patients With Bipolar I Depression: A Post Hoc Analysis of Pooled Data. *Journal of Clinical Psychopharmacology*, *41*(5), 518-525.
* Krogmann, A., Szatmári, L., Németh, G., Kiss, B., & Pál, S. (2018). Pharmacokinetics of Cariprazine in Subjects with Mild, Moderate, or Severe Renal Impairment, and in Subjects with Moderate Hepatic Impairment. *Clinical Pharmacokinetics*, *57*(7), 847-858.
* Jeste, D. V., & Krystal, J. H. (2018). Antipsychotic Prescribing for Older Adults: An Update. *The American Journal of Psychiatry*, *175*(11), 1083-1090.
* Kim, E., Tingle, K. M., & Rusk, J. (2021). Cariprazine in the treatment of schizophrenia and bipolar disorder: A review of efficacy and safety in adult and older adult populations. *Expert Review of Neurotherapeutics*, *21*(10), 1099-1111.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.